Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
P••• V••• I••••••••• L••
Innovative tools and devices improve patient outcomes and optimize surgery.
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 3 of 5 distinct vehicles are sworn Private Equity Funds; 2 reported gross assets on a filing in 2022 or later
- Size band
- Lower middle marketdefined by: proxy: $0.05bn Private Equity Fund GAV on the Form ADV filed 2024-03-26
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 3 of 5 distinct vehicles are sworn P•••••• Equity Funds; 2 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Jan 24, 2013 to Mar 26, 2024
- RAUM
- $264Mregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 1
- PE fund GAV, latest filing
- $49.5Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $147Mevery private fund type, latest filing
- 2024 PE fund GAV
- $49.5Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 60%
- Fund type mix
- filed 2024-03-26, latest gav Hedge Fund $97.3M, Private Equity Fund $49.5M, latest counts Hedge Fund 2, Private Equity Fund 1, lifetime distinct Hedge Fund 2, Private Equity Fund 3
- Employees
- 10
- Headquarters
- New York, NY
- Office address
- 545 W 25TH STREET, 19TH FLOOR, New York, NY, 10001
- Business phone
- (646) 757-2180
- Sectors
- healthcare, technology
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- As a fundamentally-driven investment manager, we focus on innovative and disruptive technologies, company life cycle changes, and structural shifts in the healthcare landscape.
- roles
- unknown 7
- period
- to unknown, from unknown, undated holdings 7, dated observations 0
- window
- last unknown, first unknown
- control
- unknown 7
- companies
- 7
- geography
- investments
- 7
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 0
- disclosed value usd
- n 0
- sector distribution
- holding period years
- n 0
- repeat counterparties
- subsector distribution
7 companies on the graph (0 transactions); no dated observations
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| P••• V••• X• F••• L• ADV: P•••••• Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $49.5M as of Mar 26, 2024 | no Form D | Unknown | |
| P••• V••• P•••••• E••••• F••• L• ADV: P•••••• Equity Fund | Buyout fund | 2016 first reported on Form ADV | $18.9M as of May 12, 2023 | no Form D | Mature | |
| P••• V••• S•• I• L•• ADV: P•••••• Equity Fund | buyout or unlabelled | 2014 first reported on Form ADV | $14.1M as of Sep 13, 2021 | no Form D | Wound down |
- E•••• J•••• K•••• · Member · since Jul 1, 2012 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- C••• F•••• B•••••••• · Cco & Cfo · since Jun 1, 2023 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
5 former (kept with end dates)
- D•••• J••••• · Member · Jan 1, 2016 to Sep 29, 2017 Inference
- F•••• I•••• L•••••• · Member · Jul 1, 2012 to Jun 30, 2023 Inference
- A••••• A•••• R••••• · Cco And Cfo · May 1, 2018 to Jun 30, 2023 Inference
- C••••••••• A••••••• N•••• · Cfo/Coo/Cco · Nov 1, 2012 to Sep 29, 2017 Inference
- M•••••• S•• B•••••• · Chief Operating Officer · Jul 1, 2021 to May 12, 2023 Inference
| Company | Role | Status | Invested | Held | Partner | Source |
|---|---|---|---|---|---|---|
| a••• L••• S••••••• A• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| C••••• M•••••• I••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| F••••••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| M••••••••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| Q••••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| S••••• I••••••••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
| W••••• I••••••••• | Role unknown | unknown | unknown | unknown | unknown | Fact Investment organization websites (team, portfolio, strategy, criteria, news) |
- Jan 24, 2013P••• V••• I••••••••• L•• first filed Form ADV in the extract (ERA)
P••• V••• I••••••••• L•• is the same institution as 2 records in Independent Sponsors and RIA and Wealth.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…